 |
| March
12, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
 |
 |
| Boston's
most flexible contract vivarium
lab space: Start with a few study
cages and grow. |
|
Learn More
→ |
|
|
- AiM Medical Robotics: Adds Surgical Robotics
Pioneer, Dr. Yulun Wang, to Its World-Class
Board More
- Decoy Therapeutics: Enters Strategic
Partnership With Quantori to Deploy Google
Cloud-native Integrated AI-Driven Peptide
Design and Molecular Simulation Platform More
- Full Circles Therapeutics: Circular
Single-Stranded DNA Platform Enabling
Immune-Evasive Genome Writing in Nature Study
More
- Insulet: Promising Study Results for Fully
Closed-Loop Automated Insulin Delivery System
for Adults With Type 2 Diabetes More
- KOMO Biosciences: Grants Research Evaluation
License to Syngenta to Explore Precision
Genome Modification in Maize More
- MeMed: FDA Grants Breakthrough Device
Designation to BV Flex Capillary Blood More
- Pretzel Therapeutics: Preclinical Data on
PX578 at MDA 2026, Further Supporting Clinical
Advancement in Individuals Living With POLG
Disease
More
- Rapid Micro Biosystems: Follow-on
Multi-System Order from Samsung Biologics to
Expand Deployment of Growth Direct Platform More
- Solid Biosciences: Interim Positive
Clinical Update on Phase 1/2 INSPIRE
DUCHENNE Trial More
More*
- Wyss Institute: Building Protection Against
Infectious Diseases With Nanostructured
Vaccines More
|
|
 |
We
help you focus on the science.
Let Charles River CFO
provide the financial insight you
need.
Flexible fractional and
interim solutions. |
|
Learn More
→ |
|
|
|
- BrainsWay: Fourth Quarter and Full Year 2025
Financial Results and Operational Highlights More
- Candel Therapeutics: Fourth Quarter and Full
Year 2025 Financial Results and Recent
Corporate Highlights More
- Foghorn Therapeutics: Financial Update for
2025 and 2026 Strategic Outlook More
- German Life Sciences Firm to Close
Framingham Site as Part of Global Cuts More*
More*
More*
More
- Harvard Bioscience: Fourth Quarter and
Full-Year 2025 Financial Results More
- More on Little-Known Cambridge Firm Planning
Public Debut to Fund Pancreatic Cancer Trial More*
- More on Vima Tacking on $40M to Series A,
Expanding Plans for Lead Programme Into
Parkinson's More*
More
- ProQR: Year End 2025 Operating and Financial
Results More
- Rapid Micro Biosystems: Record Fourth
Quarter and Full Year 2025 Financial Results
and Provides 2026 Guidance More
- Seres Therapeutics: Fourth Quarter and Full
Year 2025 Financial Results and Provides
Business Updates More
- Xilio Therapeutics: 1-for-14 Reverse Stock
Split More
|
|
|
 |
Pace®
Life Sciences
The CDMO That Takes You Further.
Your partner for Product
Development, Manufacturing,
Analytical Testing, Regulatory
Consulting & Operational
Support. |
|
Learn More
→ |
|
|
|
- How a New Tool for Large-Scale Gene Editing
Could Power Novel Genetic Medicines More
More
- More on Biogen Unveiling Phase III
Salanersen Program to Bring Longer-Acting
SMA Option More*
More*
More
- More on Skyhawk Tapping Teva Alum to Steer
Commercial Path, While Santhera Names New CCO
to Grow DMD Sales More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
 |
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- From Seed to Series C: What
Investors Look for Beyond the Science More
- ICYMI: CEO’s Perspective: Big Moves Come
with Big Responsibility More
- ICYMI: CEO’s Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- Lilly Plucks Flagship, Bluebird Vet for
Regenerative Medicine Unit; Novo’s New China
President More*
- M&A in Life Sciences: The Turning Tide –
Why Now is a Strategic Inflection for
Biopharma and Biotech More
- 6 Companies Hiring in Cambridge More
- The Rise of Fractional Talent in Life
Sciences: What to Expect in 2026 More
- 2025 Q4 Job Market Report: Positive Signs
Emerge for Job Seekers More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Boston Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Boston,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
